Evidence map›Paper›PMID 28276520›Full record

ArticleScientific reports2017

Antimicrobial peptide cWFW kills by combining lipid phase separation with autolysis.

Kathi Scheinpflug, Michaela Wenzel, Oxana Krylova, Julia E Bandow, Margitta Dathe, Henrik Strahl

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 55 papers.

0numbers the graph read from it
0cells of the map it votes in
55citing papers in PubMed
9.7field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

55 citing papers in PubMed, 114 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 2 countries.

Kathi ScheinpflugPeptide-Lipid Interaction, Leibniz-Institut für Molekulare Pharmakologie (FMP), Berlin, Germany.
Michaela WenzelApplied Microbiology, Ruhr University Bochum, Bochum, Germany.
Oxana KrylovaPeptide-Lipid Interaction, Leibniz-Institut für Molekulare Pharmakologie (FMP), Berlin, Germany.
Julia E BandowApplied Microbiology, Ruhr University Bochum, Bochum, Germany.
Margitta DathePeptide-Lipid Interaction, Leibniz-Institut für Molekulare Pharmakologie (FMP), Berlin, Germany.
Henrik StrahlCentre for Bacterial Cell Biology, Institute for Cell and Molecular Biosciences, Newcastle, University, Newcastle upon Tyne, United Kingdom.
Leibniz-Forschungsinstitut für Molekulare Pharmakologie · DERuhr University Bochum · DENewcastle University · GB

Funding

Wellcome Trust 105617/Z/14/Z
6 · The paper itself

Abstract

The synthetic cyclic hexapeptide cWFW (cyclo(RRRWFW)) has a rapid bactericidal activity against both Gram-positive and Gram-negative bacteria. Its detailed mode of action has, however, remained elusive. In contrast to most antimicrobial peptides, cWFW neither permeabilizes the membrane nor translocates to the cytoplasm. Using a combination of proteome analysis, fluorescence microscopy, and membrane analysis we show that cWFW instead triggers a rapid reduction of membrane fluidity both in live Bacillus subtilis cells and in model membranes. This immediate activity is accompanied by formation of distinct membrane domains which differ in local membrane fluidity, and which severely disrupts membrane protein organisation by segregating peripheral and integral proteins into domains of different rigidity. These major membrane disturbances cause specific inhibition of cell wall synthesis, and trigger autolysis. This novel antibacterial mode of action holds a low risk to induce bacterial resistance, and provides valuable information for the design of new synthetic antimicrobial peptides.

Indexed as

Amino Acid SequenceAnti-Bacterial AgentsAntimicrobial Cationic PeptidesBacillus subtilisBacterial ProteinsBacteriolysisCell MembraneCell WallElectric ConductivityMembrane FluidityMembrane PotentialsMembrane ProteinsPeptides, CyclicProteomeAnti-Bacterial AgentsAntimicrobial Cationic PeptidesBacterial ProteinsMembrane ProteinsPeptides, CyclicProteome

Identifiers

PMID28276520
PMCPMC5343580
OpenAlexW2593960228

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.